Over the course of the past week, the Aterian Inc (NASDAQ:ATER) stock has been in the middle of a damaging downward spiral and has slumped by as much as 29%. Considering the sheer scale of the decline, it may be the right time to take a look at the anatomy of the selloff. Last week the company announced its financial results for the second fiscal quarter and that proved to…
One of the stocks to have emerged as a notable gainer this past Friday was that of Regen Biopharma (OTCMKTS:RGBP). The stock came on to the radars of investors after the publication of the transcript of the discussion and analyses in relation to the On Friday, investors piled on to the stock in a big way as the Regen stock ended the day with gains company’s financial situation as well…
In recent weeks, Tonix Pharmaceuticals (NASDAQ:TNXP) has been in the middle of a fair bit of trouble and it has been reflected in the price action in its stock as well. The death spiral in the Tonix stock came about due to the massive setback in the interim analysis from the late stage clinical trials of one of its products. As a matter of fact, most experts believe that the…
Phunware Inc (NASDAQ:PHUN) dropped 15.5% as investors responded negatively to its Q2 2021 financial results. The company reported net revenue of $1.4 million thanks to the growth of the customer pipeline. Most of Phunware’s revenue was from subscriptions and services of the Multiscreen-as-a-Service platform, which generated revenue of $1.2 million. CEO Alan Knitowski stated that they are encouraged by the growing operational momentum the business saw in Q2 2021 despite…
As more and more companies report their quarterly financial results, it is perhaps time for investors to take a look at many of those and one of the companies one could take a look into is CNS Pharmaceuticals Inc (NASDAQ:CNSP). This past Friday the company announced its financial results for the quarter that concluded on June 30, 2021 and upon the announcement, the CNS stock ended up with gains of…
ILUS International Inc (OTCMKTS:ILUS) confirmed on August 13, 2021, being focused on M&A strategy to acquire and grow global technology firms. Releasing quarter two results of 2021, ILUS said that revenues have surged, profit has shot up and it is achieving milestones. ILUS International achieved revenue of $2.86 million in the second quarter, which is a jump of 462% over the first-quarter revenue of $ 509k. Further, ILUS confirmed that…
The personal medical alarm and security device manufacturing company Wearable Health Solutions (OTCMKTS:WHSI) has been in a lot of focus among investors in recent days. That trend continued on Thursday as investors piled on to the Wearable Health Solutions stock in a big way and sent the stock soaring by as much as 25%. There was no news about the company yesterday but at the same time it could be…
The announcement of the financial results can often have a significant effect on a company’s stock price and that is what happened with the Progenity Inc (NASDAQ:PROG) stock today. The company had its earnings call this morning and that has already resulted in a 5% fall in the stock in the premarket trading period so far. In light of the latest developments, it might be a good time for investors…
DarkPulse Inc. (OTCMKTS:DPLS) soared 25% after announced the completion of the Optilan acquisition. Optilan is a private firm incorporated in the UK to provide communication and security systems plus integration services. Its services include installation, design, support, commissioning, and maintenance services to various blue-chip companies. Optilan’s products include CCTV, perimeter detection, access control, telephony, networks, satellite communications, fiber installation, and alarms. So far, Optilan has designed a large number of…
The past week has not been particularly great for the Acasti Pharma Inc (NASDAQ:ACST) stock considering the fact that the stock has declined by as much as 5% during the period. In this situation, it might be a good idea for investors to figure out if the recent drop in the stock price might actually prove to be an opportunity to get into the Acasti stock or not. As a…
